SIRT3 and Duchenne muscular dystrophy: We opine that Sirt3 inhibitor by virtue of its beneficial effects might mitigate some, if not all, abnormal expression levels of above the molecules that are supposedly responsible for diaphragm atrophy, and alveolar leakage from the lungs in the DMD patients, and during SARS-CoV-2 infection, and subsequent COVID-19 syndrome.